All

• العربية • Català • Cymraeg • Deutsch • Español • فارسی • Français • Galego • 한국어 • Հայերեն • Hrvatski • Italiano • עברית • Lietuvių • Bahasa Melayu • Nederlands • 日本語 • Norsk bokmål • Norsk nynorsk • ଓଡ଼ିଆ • Polski • Português • Русский • ᱥᱟᱱᱛᱟᱲᱤ • Shqip • Slovenščina • Српски / srpski • Srpskohrvatski / српскохрватски • Suomi • Svenska • தமிழ் • తెలుగు • ไทย • Türkçe • Українська • اردو • Vahcuengh • Tiếng Việt • 中文 Medical condition Acute lymphoblastic leukemia Other names Acute lymphocytic leukemia, acute lymphoid leukemia Bone marrow aspirate smear from a person with precursor B-cell ALL. The large purple cells are lymphoblasts. Feeling tired, pale color, fever, easy bleeding or bruising, bone pain, Usual onset 2–5 years old Types Causes Usually unknown Treatment Children: 90% Adults: 35% five-year survival Frequency 1 in 1,750 children Deaths 111,000 (2015) Acute lymphoblastic leukemia ( ALL) is a In most cases, the cause is unknown. ALL is typically treated initially with Treatment can also include ALL affected about 876,000 people globally in 2015 and resulted in about 111,000 deaths. Signs and symptoms [ ] Initial Central nervous system (CNS) symptoms such as cranial neuropathies due to meningeal infiltration are identified in less than 10% of adults and less than 5% of children, particularly mature B-cell ALL (Burkitt leukemia) at presentation. The signs and symptoms of ALL are variable and include: • Generalized weakness and feeling tired • Anemia • Dizziness •...